{"id":"aceclofenac","rwe":[{"pmid":"41866607","year":"2026","title":"A multihued sustainable appraisal of the electrochemical method for synchronized micro-estimation of the household drug Paracetamol with Aceclofenac or Dicyclomine.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41771486","year":"2026","title":"Thermosensitive In-situ gel based on halloysite nanotube/chitosan for site-specific delivery of aceclofenac.","finding":"","journal":"Journal of pharmaceutical sciences","studyType":"Clinical Study"},{"pmid":"41722416","year":"2026","title":"Mechanistic insights into carbon dot-aceclofenac interactions: An experimental and theoretical approach.","finding":"","journal":"Journal of molecular graphics & modelling","studyType":"Clinical Study"},{"pmid":"41640924","year":"2026","title":"Acute Exacerbation of Chronic Periapical Pathology in a Dentist: An Autobiographical Case Report.","finding":"","journal":"Cureus","studyType":"Clinical Study"},{"pmid":"41621501","year":"2026","title":"Population pharmacokinetic model-based IVIVC incorporating active metabolite kinetics: Application to aceclofenac sustained-release formulations.","finding":"","journal":"International journal of pharmaceutics","studyType":"Clinical Study"}],"tags":[{"label":"aceclofenac","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Transthyretin","category":"target"},{"label":"TTR","category":"gene"},{"label":"MAPK1","category":"gene"},{"label":"PTGS2","category":"gene"},{"label":"M01AB16","category":"atc"},{"label":"Oral","category":"route"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Adhesive capsulitis of shoulder","category":"indication"},{"label":"Ankylosing spondylitis","category":"indication"},{"label":"Backache","category":"indication"},{"label":"Osteoarthritis","category":"indication"},{"label":"Rheumatoid arthritis","category":"indication"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Non-Narcotic","category":"pharmacology"},{"label":"Anti-Inflammatory Agents","category":"pharmacology"},{"label":"Anti-Inflammatory Agents, Non-Steroidal","category":"pharmacology"},{"label":"Antirheumatic Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":299.787,"date":"","count":64,"signal":"Amaurosis fugax","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=300)"},{"llr":263.36,"date":"","count":66,"signal":"Ocular discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=263)"},{"llr":260.77,"date":"","count":64,"signal":"Urinary tract disorder","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=261)"},{"llr":244.382,"date":"","count":68,"signal":"Haemorrhagic stroke","source":"DrugCentral FAERS","actionTaken":"Reported 68 times (LLR=244)"},{"llr":209.538,"date":"","count":64,"signal":"Head discomfort","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=210)"},{"llr":192.349,"date":"","count":66,"signal":"Generalised oedema","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=192)"},{"llr":191.258,"date":"","count":64,"signal":"Photophobia","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=191)"},{"llr":178.516,"date":"","count":71,"signal":"Altered state of consciousness","source":"DrugCentral FAERS","actionTaken":"Reported 71 times (LLR=179)"},{"llr":171.502,"date":"","count":65,"signal":"Blindness","source":"DrugCentral FAERS","actionTaken":"Reported 65 times (LLR=172)"},{"llr":167.781,"date":"","count":65,"signal":"Diplopia","source":"DrugCentral FAERS","actionTaken":"Reported 65 times (LLR=168)"},{"llr":163.016,"date":"","count":66,"signal":"Presyncope","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=163)"},{"llr":162.479,"date":"","count":66,"signal":"Eye pain","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=162)"},{"llr":150.787,"date":"","count":66,"signal":"Haematemesis","source":"DrugCentral FAERS","actionTaken":"Reported 66 times (LLR=151)"},{"llr":148.497,"date":"","count":65,"signal":"Tinnitus","source":"DrugCentral FAERS","actionTaken":"Reported 65 times (LLR=148)"},{"llr":146.968,"date":"","count":71,"signal":"Haematuria","source":"DrugCentral FAERS","actionTaken":"Reported 71 times (LLR=147)"}],"commonSideEffects":[{"effect":"Dyspepsia","drugRate":"","severity":"common","organSystem":""},{"effect":"Abdominal pain","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Rash","drugRate":"","severity":"common","organSystem":""},{"effect":"Urticaria","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Drowsiness","drugRate":"","severity":"common","organSystem":""},{"effect":"Ruber","drugRate":"","severity":"common","organSystem":""},{"effect":"Enuresis","drugRate":"","severity":"common","organSystem":""}],"specialPopulations":{"Pregnancy":"Since there is no information on the safe use of CLANZA CR during pregnancy and lactation, the use of CLANZA CR should therefore be avoided in pregnancy and lactation.","Paediatric use":"The dosage and indication is not established yet for children with less than years old."},"seriousAdverseEvents":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ACECLOFENAC","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:16:27.139929+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-19T23:16:43.201125+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:16:33.039009+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACECLOFENAC","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:16:33.387518+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase-2 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:16:34.545803+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL93645/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:16:34.191023+00:00"}},"allNames":"hifenac","offLabel":[],"synonyms":["aceclofenac","aceclofar","hifenac"],"timeline":[],"aiSummary":"Aceclofenac (Hifenac) is a marketed nonsteroidal anti-inflammatory drug (NSAID) primarily indicated for adhesive capsulitis of the shoulder, competing in a crowded NSAID market with several off-patent generics and patent-protected alternatives. Its key strength lies in its mechanism of action, which effectively inhibits prostaglandin production to reduce pain and inflammation, potentially offering a differentiated efficacy profile compared to older NSAIDs. The primary risk is the expiration of its key composition patent in 2028, which could lead to increased competition from generics and erode market share.","brandName":"Hifenac","ecosystem":[{"indication":"Adhesive capsulitis of shoulder","otherDrugs":[{"name":"diclofenac","slug":"diclofenac","company":""}],"globalPrevalence":null},{"indication":"Ankylosing spondylitis","otherDrugs":[{"name":"adalimumab","slug":"adalimumab","company":"Abbvie Inc"},{"name":"betamethasone","slug":"betamethasone","company":""},{"name":"betamethasone acetate","slug":"betamethasone-acetate","company":""},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"}],"globalPrevalence":64000000},{"indication":"Backache","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"caffeine","slug":"caffeine","company":"Novartis"},{"name":"camphor","slug":"camphor","company":""},{"name":"capsaicin","slug":"capsaicin","company":"Acorda"}],"globalPrevalence":null},{"indication":"Osteoarthritis","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"},{"name":"choline magnesium trisalicylate","slug":"choline-magnesium-trisalicylate","company":""},{"name":"diclofenac","slug":"diclofenac","company":""}],"globalPrevalence":655000000},{"indication":"Rheumatoid arthritis","otherDrugs":[{"name":"abatacept","slug":"abatacept","company":"Bristol Myers Squibb"},{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"adalimumab","slug":"adalimumab","company":"Abbvie Inc"},{"name":"anakinra","slug":"anakinra","company":"Biovitrum Ab"}],"globalPrevalence":18000000}],"mechanism":{"target":"Transthyretin","novelty":"First-in-class","targets":[{"gene":"TTR","source":"DrugCentral","target":"Transthyretin","protein":"Transthyretin"},{"gene":"MAPK1","source":"DrugCentral","target":"Mitogen-activated protein kinase 1","protein":"Mitogen-activated protein kinase 1"},{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"}],"modality":"Small Molecule","drugClass":"aceclofenac","explanation":"","oneSentence":"","technicalDetail":"Hifenac exerts its anti-inflammatory and analgesic effects by selectively inhibiting the enzyme cyclooxygenase-2 (COX-2), which is responsible for the production of prostaglandins."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/43","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ACECLOFENAC","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACECLOFENAC","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T07:27:14.322013","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:16:43.201225+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"indomethacin","drugSlug":"indomethacin","fdaApproval":"1965-06-10","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"sulindac","drugSlug":"sulindac","fdaApproval":"1978-09-27","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tolmetin","drugSlug":"tolmetin","fdaApproval":"1976-03-24","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"diclofenac","drugSlug":"diclofenac","fdaApproval":"1988-07-28","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"etodolac","drugSlug":"etodolac","fdaApproval":"1991-01-31","genericCount":25,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketorolac","drugSlug":"ketorolac","fdaApproval":"1989-11-30","patentExpiry":"Nov 24, 2027","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"aceclofenac","indications":{"approved":[{"name":"Adhesive capsulitis of shoulder","source":"DrugCentral","snomedId":399114005,"regulator":"FDA"},{"name":"Ankylosing spondylitis","source":"DrugCentral","snomedId":9631008,"regulator":"FDA","usPrevalence":null,"globalPrevalence":64000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Care Res (Hoboken), 2016 (PMID:26713432)"},{"name":"Backache","source":"DrugCentral","snomedId":161891005,"regulator":"FDA"},{"name":"Osteoarthritis","source":"DrugCentral","snomedId":396275006,"regulator":"FDA","usPrevalence":null,"globalPrevalence":655000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Res Ther, 2023 (PMID:36991481)"},{"name":"Rheumatoid arthritis","source":"DrugCentral","snomedId":69896004,"regulator":"FDA","eligibility":"No specific eligibility criteria mentioned","usPrevalence":1500000,"globalPrevalence":18000000,"prevalenceMethod":"curated","prevalenceSource":"Lancet Rheumatology, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"indomethacin","brandName":"indomethacin","genericName":"indomethacin","approvalYear":"1965","relationship":"same-class"},{"drugId":"sulindac","brandName":"sulindac","genericName":"sulindac","approvalYear":"1978","relationship":"same-class"},{"drugId":"tolmetin","brandName":"tolmetin","genericName":"tolmetin","approvalYear":"1976","relationship":"same-class"},{"drugId":"diclofenac","brandName":"diclofenac","genericName":"diclofenac","approvalYear":"1988","relationship":"same-class"},{"drugId":"etodolac","brandName":"etodolac","genericName":"etodolac","approvalYear":"1991","relationship":"same-class"},{"drugId":"ketorolac","brandName":"ketorolac","genericName":"ketorolac","approvalYear":"1989","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05980572","phase":"NA","title":"Effects of App-assisted Home Exercise Program in Patients With Frozen Shoulder","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-09-11","conditions":["Frozen Shoulder"],"enrollment":21,"completionDate":"2023-12-31"},{"nctId":"NCT05558150","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2022-11-10","conditions":["Drug Interaction Potentiation"],"enrollment":24,"completionDate":"2022-12-22"},{"nctId":"NCT05339373","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2022-04-15","conditions":["Bioequivalence"],"enrollment":36,"completionDate":"2022-08-15"},{"nctId":"NCT05237297","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2022-02-17","conditions":["Drug Interaction Potentiation"],"enrollment":72,"completionDate":"2022-07-27"},{"nctId":"NCT02883569","phase":"NA","title":"Comparative Effectiveness Study for Surgery vs. Non-Surgery in Patients With Low Back Pain","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-09","conditions":["Low Back Pain"],"enrollment":1102,"completionDate":"2021-12"},{"nctId":"NCT02384928","phase":"NA","title":"Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Jaseng Medical Foundation","startDate":"2015-09-09","conditions":["Sciatica","Intervertebral Disc Displacement"],"enrollment":60,"completionDate":"2017-03-16"},{"nctId":"NCT05181124","phase":"PHASE1","title":"Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian","status":"COMPLETED","sponsor":"Onconic Therapeutics Inc.","startDate":"2021-03-05","conditions":["Anti-Ulcer Agents"],"enrollment":88,"completionDate":"2021-03-23"},{"nctId":"NCT04639804","phase":"PHASE1","title":"Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2020-06-06","conditions":["Healthy"],"enrollment":60,"completionDate":"2020-07-29"},{"nctId":"NCT04144101","phase":"PHASE4","title":"Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2007-03-01","conditions":["Rheumatoid Arthritis"],"enrollment":40,"completionDate":"2007-07-31"},{"nctId":"NCT02289274","phase":"PHASE1","title":"Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203","status":"WITHDRAWN","sponsor":"NVP Healthcare","startDate":"2019-11","conditions":["Healthy"],"enrollment":0,"completionDate":"2019-12"},{"nctId":"NCT03911570","phase":"","title":"Crystalline Glucosamine Sulfate Therapy in Hand Osteoarthritis","status":"COMPLETED","sponsor":"University of Siena","startDate":"2018-09-01","conditions":["Hand Osteoarthritis"],"enrollment":108,"completionDate":"2019-02-01"},{"nctId":"NCT03335007","phase":"PHASE2,PHASE3","title":"Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-05","conditions":["Symptomatic Irreversible Pulpitis"],"enrollment":70,"completionDate":"2017-07"},{"nctId":"NCT03146481","phase":"PHASE2,PHASE3","title":"Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07","conditions":["Irreversible Pulpitis"],"enrollment":70,"completionDate":"2017-07"},{"nctId":"NCT03127046","phase":"PHASE1","title":"Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers","status":"UNKNOWN","sponsor":"Dong Wha Pharmaceutical Co. Ltd.","startDate":"2017-03-31","conditions":["Healthy"],"enrollment":30,"completionDate":"2017-04-23"},{"nctId":"NCT02682524","phase":"PHASE4","title":"Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2015-08","conditions":["Osteoarthritis of Knee"],"enrollment":191,"completionDate":"2016-03"},{"nctId":"NCT01952314","phase":"PHASE3","title":"Medical Expulsive Therapy for Ureter Stone Using Naftopidil","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-05","conditions":["Ureter Stones"],"enrollment":150,"completionDate":"2015-08"},{"nctId":"NCT01959074","phase":"PHASE3","title":"The Effect of Naftopidil for the Double-J Stent Discomfort","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-05","conditions":["Disorder of Urinary Stent"],"enrollment":100,"completionDate":"2015-06"},{"nctId":"NCT01912066","phase":"PHASE4","title":"A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2012-09","conditions":["NSAID-associated Gastroduodenal Injury"],"enrollment":520,"completionDate":"2014-03"},{"nctId":"NCT01638286","phase":"","title":"Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2012-08","conditions":["Acute Low Back Pain"],"enrollment":24,"completionDate":"2013-04"},{"nctId":"NCT01869985","phase":"PHASE1","title":"Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2013-08","conditions":["Healthy"],"enrollment":30,"completionDate":"2014-01"},{"nctId":"NCT00635349","phase":"PHASE4","title":"A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2007-05","conditions":["Osteoarthritis"],"enrollment":143,"completionDate":"2009-04"},{"nctId":"NCT00647517","phase":"PHASE4","title":"Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Chung Shan Medical University","startDate":"2008-03","conditions":["Ankylosing Spondylitis"],"enrollment":60,"completionDate":"2009-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Tablet","formulations":[{"form":"TABLET, FILM COATED","route":"ORAL","productName":"ClanzaCR"}]},"crossReferences":{"NDDF":"005957","UNII":"RPK779R03H","CHEBI":"CHEBI:31159","INN_ID":"5608","RXNORM":"16689","UMLSCUI":"C0050403","chemblId":"CHEMBL93645","ChEMBL_ID":"CHEMBL93645","KEGG_DRUG":"D01545","DRUGBANK_ID":"DB06736","PUBCHEM_CID":"71771","SNOMEDCT_US":"329923004","MESH_SUPPLEMENTAL_RECORD_UI":"C056498"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":549,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"M01AB16","allCodes":["M01AB16","M02AA25"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 22","pmid":"41866607","title":"A multihued sustainable appraisal of the electrochemical method for synchronized micro-estimation of the household drug Paracetamol with Aceclofenac or Dicyclomine.","journal":"Scientific reports"},{"date":"2026 Feb 28","pmid":"41771486","title":"Thermosensitive In-situ gel based on halloysite nanotube/chitosan for site-specific delivery of aceclofenac.","journal":"Journal of pharmaceutical sciences"},{"date":"2026 May","pmid":"41722416","title":"Mechanistic insights into carbon dot-aceclofenac interactions: An experimental and theoretical approach.","journal":"Journal of molecular graphics & modelling"},{"date":"2026 Jan","pmid":"41640924","title":"Acute Exacerbation of Chronic Periapical Pathology in a Dentist: An Autobiographical Case Report.","journal":"Cureus"},{"date":"2026 Mar 10","pmid":"41621501","title":"Population pharmacokinetic model-based IVIVC incorporating active metabolite kinetics: Application to aceclofenac sustained-release formulations.","journal":"International journal of pharmaceutics"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-19T23:16:43.201225+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}